RCMI Coordinating Center (RCMI CC) Header Logo

Mahua Sarkar

TitleDr.
Faculty RankSr. Research Scientist
InstitutionTexas Southern University
DepartmentPharmaceutical Sciences
Address3100 Cleburne Street
Houston TX 77004
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Sarkar M, Ma J, Tapadar S, Caggia S, Oyelere AK, Khan SA, Xie H. Development and validation of a sensitive LC-MS/MS assay of GT-14, a novel Gai2 inhibitor, in rat plasma, and its application in pharmacokinetic study. J Pharm Biomed Anal. 2024 Aug 01; 245:116183. PMID: 38744031.
      Citations:    Fields:    Translation:AnimalsCells
    2. Gupta R, Chen Y, Sarkar M, Xie H. Surfactant Mediated Accelerated and Discriminatory In Vitro Drug Release Method for PLGA Nanoparticles of Poorly Water-Soluble Drug. Pharmaceuticals (Basel). 2022 Nov 29; 15(12). PMID: 36558940.
      Citations:    
    3. Sarkar M, Wang Y, Ekpenyong O, Liang D, Xie H. Pharmacokinetic behaviors of soft nanoparticulate formulations of chemotherapeutics. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 03; 15(2):e1846. PMID: 35979879.
      Citations: 8     Fields:    Translation:Humans
    4. Nguyen A, Chow DS, Wu L, Teng YA, Sarkar M, Toups EG, Harrop JS, Schmitt KM, Johnson MM, Guest JD, Aarabi B, Shaffrey CI, Boakye M, Frankowski RF, Fehlings MG, Grossman RG. Longitudinal Impact of Acute Spinal Cord Injury on Clinical Pharmacokinetics of Riluzole, a Potential Neuroprotective Agent. J Clin Pharmacol. 2021 09; 61(9):1232-1242. PMID: 33908635.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    5. Sarkar M, Grossman RG, Toups EG, Chow DS. Rational design and development of a stable liquid formulation of riluzole and its pharmacokinetic evaluation after oral and IV administrations in rats. Eur J Pharm Sci. 2018 Dec 01; 125:1-10. PMID: 30201516.
      Citations: 4     Fields:    Translation:Animals
    6. Sarkar M, Grossman RG, Toups EG, Chow DS. UPLC-MS/MS assay of riluzole in human plasma and cerebrospinal fluid (CSF): Application in samples from spinal cord injured patients. J Pharm Biomed Anal. 2017 Nov 30; 146:334-340. PMID: 28917164.
      Citations: 3     Fields:    Translation:Humans
    Sarkar's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (43)
    Explore
    _
    Co-Authors (5)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

    For technical support please contact support